Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
New Egyptian Journal of Medicine [The]. 1992; 6 (4): 951-4
in English | IMEMR | ID: emr-25406

ABSTRACT

This study included 30 cases in two groups. The first group is 20 cases undergoing vaginal cerclage [17 McDonald 3 modified Shirodkar]. Three samples were taken from every case, one before induction of anaesthesia and second after induction of anaesthesia and the third after completing the procedure, the levels of PGF 2 in plasma were measured, the mean level before induction of anesthesia was [434.75 +/- 618.56] and increased after induction of anesthesia [443.15 +/- 559.68] and increased again after completing the procedure [444.6 +/- 600.59]. The second group is 10 pregnant cases as control, two blood samples were taken from every case five minute before and after P.V. The mean level of PGF2 before P.V, was [885.4 +/- 793.84] and after P.V. was [680.80 +/- 803.24]. As the statical difference is not significant so we recommend that no need to routine administration of prostaglandin synthetase inhibitors during vaginal cerclage


Subject(s)
Humans , Female , Pregnancy , General Surgery , Blood Chemical Analysis , Radioimmunoassay/instrumentation
2.
New Egyptian Journal of Medicine [The]. 1992; 6 (4): 955-7
in English | IMEMR | ID: emr-25407

ABSTRACT

125 cases with PCO on ultrasound, under went detailed clinical and endocrine evaluation the age matched control group comprised volunteers with normal ovaris on ultrasound and regular ovulatory cycles. Both group were subjected to ultrasound examination and radioimmunassay for E2, FSH, LH testosterone, and androstenedion and DHEAS. 32.8 percent of PCO patient were found to have ovarian volume within normal range while 67.2 percent had enlargement overasis, and there was a significant positive correlation between ovaries volume and serum LH [P=0.56, P<0.05] testosterone R=0.46 P<0.05] and androstenedion R=0.42, P<0.05] and DHEAs levels R=0.48, P<0.05


Subject(s)
Humans , Female , Ovarian Cysts/diagnostic imaging , Androgens , Ovary/anatomy & histology , Follicle Stimulating Hormone/blood , Luteinizing Hormone/blood , Radioimmunoassay/instrumentation
3.
New Egyptian Journal of Medicine [The]. 1992; 6 (4): 958-62
in English | IMEMR | ID: emr-25408

ABSTRACT

This work is done to evaluate the effect of royal jelly on infertility resulting from disturbance of hormones controlling ovulation, and to determine its mode of action after comparing it with a well established material of effect and mode of action; clomiphene citrate. The studied cases were divided into 2 groups; Croup I: 20 married females: infertility treated with royal jelly as 1 gm. sublingually from the 5th to 9th days of menstrual cycle for a single cycle. Group II: 10 married females suffering from primary infertility treated with clomid as 50 mg. tab. orally twice daily from the 5th to 9th days of mestrual cycle for a single cycle. All cases were subjected to through history taking and clinical examination to exclude any medical disorder. Serum levels of F.S.H., L.H., progesterone and prolactin were measured by RIA technique before and after treatment with either clomid or royal jelly on the day 21st of the cycle. It was found that royal jelly significantly increased the mean levels F.S.H., L.H. and progesterone, but had no significant effect on prolactin. Clomid surpassed royal jelly and significantly increased the mean levels of F.S.H., L.T. and progestrone and significantly decreased that of prolactin


Subject(s)
Female , Follicle Stimulating Hormone/blood , Luteinizing Hormone/blood , Prolactin/blood , Infertility, Female
SELECTION OF CITATIONS
SEARCH DETAIL